The immunogenicity of Gardasil was assessed in 8,915 (Gardasil n = 4,666; placebo n = 4,249) women 18 to 26 years of age and 3,400 female (Gardasil n = 1,471; placebo n = 583) and male (Gardasil n = 1,071; placebo n = 275) adolescents 9 to 17 years of age.
A Gardasil immunogenitását 8915, 18- 26 éves nőben (Gardasil n = 4666; placebo n = 4249), valamint 3400, 9- 17 éves serdülő lányban (Gardasil n = 1471; placebo n = 583) és serdülő fiúban (Gardasil n = 1471; placebo n = 275) értékelték.